HLA-DR and -DQ gene polymorphism in Latvian patients with insulin-dependent diabetes mellitus

Tissue Antigens

Volumn 52, Issue 4, 1998, Pages 385-388

  Shtauvere, A ^a,b   Rumba, I ^b   Dzivite, I ^b   Sanjeevi, C B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b RIGA STRADINS UNIVERSITY   (Latvia)

Author keywords

GAD65 antibodies; Genetic susceptibility; HLA DQ; HLA DR; ICA512 antibodies; IDDM

Indexed keywords

AUTOANTIBODY; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATVIA; MAJOR CLINICAL STUDY; POPULATION GENETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SWEDEN;

EID: 0031691485     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03060.x     Document Type: Article

References (22)

1. Sanjeevi CB, Lybrand T, DeWeese C et al. Polymorphic aminoacid variations in HLA-DQ are associated with systematic physical property changes and occurrence of insulin-dependent diabetes mellitus. Diabetes 1995: 44: 125-31.
2. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark Å. HLA-DQ primarily confers protection and HLA-DR susceptibility in Type 1 (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet 1993: 53: 150-67.
3. Sanjeevi CB, Landin-Olsson M, Kockum I, Dahlqvist G, Lernmark Å. Effects of the second haplotype on the association with childhood insulin-dependent diabetes mellitus. Tissue Antigens 1995: 45: 148-52.
4. Sanjeevi CB, Lybrand TP, Landin-Olsson M et al. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2 positive patients with insulin-dependent diabetes mellitus. Tissue Antigens 1994: 44: 110-9.
5. Sanjeevi CB, Kockum I, Lernmark Å. The role of major histocompatibility complex in insulin-dependent diabetes. Current Opinion in Endocrinology and Diabetes 1995: 2: 3-11.
6. Nepom GT. A unified hypothesis for the complex genetics of HLA associations. Diabetes 1990: 39: 1153-7.
7. Sanjeevi CB, DeWeese C, Landin-Olsson M et al. Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus. Tissue Antigens 1997: 50: 61-5.
8. Lernmark Å, Freedman ZR, Hofmann C et al. Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med 1978: 299: 375-80.
9. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982: 298: 167-9.
10. Palmer JP, Asplin CM, Clemons P et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983: 222: 1337-9.
11. Rabin D, Pleasic S, Shapiro J et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 1994: 152: 3183-8.
12. Hagopian W, Sanjeevi CB, Kockum I et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995: 95: 1505-11.
13. Landin-Olsson M, Karlsson FA, Lernmark Å, Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15-34 years old patients in the Diabetes Incidence Study in Sweden (DISS). Diabetes 1992: 41: 1022-7.
14. Tuomilehto J. Epidemiology of childhood diabetes in the Baltic area. Nord Med 1992: 107: 244-6.
15. Karvonen M, Tuomilehto J, Libman I, LaPorte R, Group F. A review of the recent epidemiological data on incidence of type I diabetes mellitus worldwide. Diabetologia 1993: 36: 883-92.
16. Sanjeevi CB, Seshiah V, Möller E, Olerup O. Different genetic background for Type 1 diabetes and malnutrition related diabetes in South Indians. Diabetologia 1992: 35: 283-6.
17. Sanjeevi CB, Zeidler A, Shaw S et al. Analysis of HLA-DQA1 and -DQB1 genes in Mexican Americans with insulin-dependent diabetes mellitus. Tissue Antigens 1993: 38: 72-7.
18. Rabin D, Pleasic S, Palmer-Crocker R, Shapiro J. Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992: 41: 183-6.
19. Lan M, Lu J, Goto Y, Notkins A. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994: 13: 505-14.
20. Rønningen KS, Spurkland A, Tait BD et al. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids, and Japanese. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991 -Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol 1. Oxford: Oxford University Press, 1991: 713-22.
21. Sanjeevi CB, Hagopian W, Landin-Olsson M et al. Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with IDDM reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8. Tissue Antigens 1998: 51: 281-6.
22. Genovese S, Bonfanti R, Bazzigaluppi E et al. Association of IA-2 autoantibodies with DR4 phenotypes in IDDM. Diabetologia 1996: 39: 1223-6.